Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   
OVERLAP
26%

OVERLAP
BY WEIGHT
12

# OF OVERLAPPING
HOLDINGS
CANC
52
HOLDINGS
23%
ALSO IN IDNA
IDNA
44
HOLDINGS
32%
ALSO IN CANC
SECTOR DRIFT (CANC minus IDNA)
OVERLAPPING HOLDINGS

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in CANC
Weight
in IDNA
Overlap
REVOLUTION MEDICINES, INC. 7.5% 6.1% 6.1%
ASTRAZENECA PLC 4.0% 4.1% 4.0%
EXELIXIS INC 2.8% 3.3% 2.8%
CELCUITY INC. 2.6% 5.7% 2.6%
ARCELLX, INC. 2.4% 3.4% 2.4%
CANC Overweight Relative to IDNA
ELI LILLY & CO 5.8%
BRIDGEBIO PHARMA, INC. 4.4%
ROCHE HOLDINGS LTD-SPONS ADR 4.0%
COGENT BIOSCIENCES INC 3.9%
GENMAB A/S SPONSORED ADR 3.8%
NOVARTIS AG 3.5%
NUVALENT, INC. CLASS A 3.4%
IDEAYA BIOSCIENCES, INC. 2.7%
JOHNSON & JOHNSON 2.5%
ABBVIE INC 2.4%
CANC Underweight Relative to IDNA
INCYTE CORP -4.9%
GENMAB A/S -4.6%
ROCHE HOLDING LTD -3.8%
GSK PLC -3.7%
REGENERON PHARMACEUTICALS -3.7%
TWIST BIOSCIENCE CORP. -3.3%
SANOFI-AVENTIS -3.2%
TAKEDA PHARMACEUTICAL CO LTD -3.1%
BIONTECH SE SPONSORED ADR -3.1%
CELCUITY INC. -3.1%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY